HAMP and tuberculosis: Compared to those starting TB treatment more than 60 days after cohort enrollment, the cases had significantly higher serum hepcidin and ferritin levels at cohort enrollment with median (IQR) serum levels for hepcidin of 16.1 nM (8.4–20.6 nM) vs. 5.8 nM (4.1–14.1 nM; p = 0.01) and for ferritin of 1206 μg/l (591–1799 μg/l) vs. 310 μg/l (190–887 μg/l; p = 0.004), despite the fact that clinical and radiological examination showed no signs for TB at cohort enrollment.